Pharmacists expand access to reproductive heaLthcare: PEARL study protocol

Rodríguez, María I.; Darney, Blair G.; Edelman, Alison; Yee, Kimberly; Anderson, Lorinda; McConnell, K. John

doi:10.1186/s12913-019-4038-9

Cited by 7 publications

(3 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We used the baseline wave of a prospective cohort study of women presenting for contraception in pharmacies across 4 states in this analysis. 20 The full study is powered to detect a 10% difference in contraceptive continuation rates at 1 year. 5,20 All analyses and reporting of results were conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for cohort studies.…”

Section: Methodsmentioning

confidence: 99%

“…20 The full study is powered to detect a 10% difference in contraceptive continuation rates at 1 year. 5,20 All analyses and reporting of results were conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for cohort studies. 21 The institutional review board at Oregon Health & Science University approved the study protocol, and all participants provided written informed consent.…”

Section: Methodsmentioning

confidence: 99%

“…We used the baseline wave of a prospective cohort study of women presenting for contraception in pharmacies across 4 states in this analysis . The full study is powered to detect a 10% difference in contraceptive continuation rates at 1 year STROBE) reporting guideline for cohort studies .…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Association of Pharmacist Prescription With Dispensed Duration of Hormonal Contraception

et al. 2020

Self Cite

View full text Add to dashboard Cite

IMPORTANCE Since 2016, 11 states have expanded the scope of pharmacists to include direct prescription of hormonal contraception. Dispensing greater than 1 month's supply is associated with improved contraceptive continuation rates and fewer breaks in coverage. Scant data exist on the practice of pharmacist prescription of contraception and its outcomes compared with traditional, clinic-based prescriptions. OBJECTIVETo compare the amount of hormonal contraceptive supply dispensed between pharmacists and clinic-based prescriptions. Prescribing patterns were assessed by describing prescribing practices for women with contraindications to combined hormonal contraception.Characteristics of women seeking hormonal contraception directly from pharmacists were also described. DESIGN, SETTING, AND PARTICIPANTSThis cohort study surveyed women aged 18 to 50 years who presented to pharmacies in California, Colorado, Hawaii, and Oregon for hormonal contraception prescribed by a clinician or a pharmacist between January 30 and November 1, 2019. EXPOSURES Pharmacist or clinic-based prescription of contraception. MAIN OUTCOMES AND MEASURES Months of contraceptive supply dispensed. RESULTS Four hundred ten women (mean [SD] age, 27.1 [7.7] years) were recruited who obtained contraception directly from a pharmacist (n = 144) or by traditional clinician prescription (n = 266).Women obtaining contraception from a pharmacist were significantly younger (82 [56.9%] vs 115 [43.2%] participants aged 18-24 years; P = .03), had less education (38 [26.4%] vs 100 [37.6%] with a bachelor degree; P = .002), and were more likely to be uninsured (16 [11.1%] vs 8 [3.0%] participants; P = .001) compared with women with a prescription from a clinician. Pharmacists were significantly more likely to prescribe a 6-month or greater supply of contraceptives than clinicians (6.9% vs 1.5%, P < .001) and significantly less likely to only prescribe a 1-month supply (42 [29.2%] vs 118 [44.4%] prescriptions; P < .001). Controlling for all covariates, women seen by pharmacists had higher odds of receipt of a 6-month or greater supply of contraceptives compared with those seen by clinicians (odds ratio = 3.55; 95% CI, 1.88-6.70). Pharmacists were as likely as clinicians to prescribe a progestin-only method to women with a potential contraindication to estrogen (n = 60 women; 8 [20.0%] vs 6 [30.0%], P = .52). CONCLUSIONS AND RELEVANCEThese findings suggest that pharmacist prescription of contraception may be associated with improved contraceptive continuation by preventing breaks in coverage through the provision of a greater supply of medication. Efforts are needed to educate prescribing providers on the importance of dispensing 6 months or greater contraceptive supply.

show abstract

Section: Methodsmentioning

confidence: 99%